Skip Navigation

European Heart Journal 2002 23(16):1246-1252; doi:10.1053/euhj.2002.3287
Copyright © 2002 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Antzelevitch, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Antzelevitch, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorials

Sympathetic modulation of the long QT syndrome

C. Antzelevitch

Masonic Medical Research Laboratory, Utica, New York, U.S.A.

References

  1. Schwartz PJ. The idiopathic long QT syndrome: progress and questions. Am Heart J. 1985;109:399–411[CrossRef][ISI][Medline]
  2. Moss AJ, Schwartz PJ, Crampton RS. The long QT syndrome: prospective longitudinal study of 328 families. Circulation. 1991;84:1136–1144[Abstract/Free Full Text]
  3. Zipes DP. The long QT syndrome: A Rosetta stone for sympathetic related ventricular tachyarrhythmias. Circulation. 1991;84:1414–1419[Free Full Text]
  4. Wang Q, Shen J, Splawski I. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell. 1995;80:805–811[CrossRef][ISI][Medline]
  5. Curran ME, Splawski I, Timothy KW. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell. 1995;80:795–803[CrossRef][ISI][Medline]
  6. Wang Q, Curran ME, Splawski I. Positional cloning of a novel potassium channel gene: KVLTQ1 mutations cause cardiac arrhythmias. Nat Genet. 1996;12:17–23[CrossRef][ISI][Medline]
  7. Splawski, I, Tristani-Firouzi, M, Lehmann, MH, Mutations in the hminK gene cause long QT syndrome and suppress IKs function. Nat Genet, 1997, 17, 338, 40
  8. Plaster NM, Tawil R, Tristani-Firouzi M. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell. 2001;105:511–519[CrossRef][ISI][Medline]
  9. Sanguinetti MC, Jiang C, Curran ME. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell. 1995;81:299–307[CrossRef][ISI][Medline]
  10. Abbot GW, Sesti F, Splawski I. MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell. 1999;97:175–187[CrossRef][ISI][Medline]
  11. Sanguinetti MC, Curran ME, Zou AR. Coassembly of KvLQT1 and minK (IsK) proteins to form cardiac IKs potassium channel. Nature. 1996;384:80–83[CrossRef][Medline]
  12. Barhanin J, Lesage F, Guillemare E. KvLQT1 and IsK (minK) proteins associate to form the IKs cardiac potassium current. Nature. 1996;384:78–80[CrossRef][Medline]
  13. Schwartz PJ, Priori SG, Spazzolini C. Genotype–phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation. 2001;103:89–95[Abstract/Free Full Text]
  14. Hodgkin AL, Huxley AF. Currents carried by sodium and potassium ions through the membrane of the giant axon of Loligo. J Physiol (Lond). 1952;116:449–472[Free Full Text]
  15. Moss AJ, Robinson JL, Gessman L. Comparison of clinical and genetic variables of cardiac events associated with loud noise versus swimming among subjects with the long QT syndrome. Am J Cardiol. 1999;84:876–879[CrossRef][ISI][Medline]
  16. Ackerman MJ, Tester DJ, Porter CJ. Swimming, a gene-specific arrhythmogenic trigger for inherited long QT syndrome. Mayo Clin Proc. 1999;74:1088–1094[ISI][Medline]
  17. Wilde AAM, Jongbloed RJE, Doevendans PA. Auditory stimuli as a trigger for arrhythmic events differentiate HERG-related (LQTS2) patients from KVLQT1-related patients (LQTS1). J Am Coll Cardiol. 1999;33:327–332[Abstract/Free Full Text]
  18. Wit AL, Rosen MR. Afterdepolarizations and triggered activity: distinction from automaticity as an arrhythmogenic mechanism. Fozzard HA. The Heart and Cardiovascular System. New York: Raven Press; 1992. p. 2113–2164
  19. Yan GX, Wu Y, Liu T. Phase 2 early afterdepolarization as a trigger of polymorphic ventricular tachycardia in acquired long-qt syndrome: direct evidence from intracellular recordings in the intact left ventricular wall. Circulation. 2001;103:2851–2856[Abstract/Free Full Text]
  20. Antzelevitch C, Shimizu W. Cellular mechanisms underlying the Long QT syndrome. Curr Opin Cardiol. 2002;17:43–51[CrossRef][ISI][Medline]
  21. Akar FG, Yan GX, Antzelevitch C. Unique topographical distribution of M cells underlies reentrant mechanism of torsade de pointes in the long-QT syndrome. Circulation. 2002;105:1247–1253[Abstract/Free Full Text]
  22. Kozhevnikov DO, Yamamoto K, Robotis D. Electrophysiological mechanism of enhanced susceptibility of hypertrophied heart to acquired torsade de pointes arrhythmias: tridimensional mapping of activation and recovery patterns. Circulation. 2002;105:1128–1134[Abstract/Free Full Text]
  23. El-Sherif N. Polymorphic ventricular tachycardia and torsades de pointes: beyond etymology. J Cardiovasc Electrophysiol. 2001;12:695–696[CrossRef][ISI][Medline]
  24. Schmitt H, Cabo C, Costeas C. Mechanisms for spontaneous changes in QRS morphology sometimes resembling torsades de pointes during reentrant ventricular tachycardia in a canine infarct model. J Cardiovasc Electrophysiol. 2001;12:686–694[CrossRef][ISI][Medline]
  25. Eckardt L, Haverkamp W, Borggrefe M. Experimental models of torsade de pointes. Cardiovasc Res. 1998;39:178–193[Abstract/Free Full Text]
  26. Antzelevitch C, Sicouri S. Clinical relevance of cardiac arrhythmias generated by afterdepolarizations: The role of M cells in the generation of U waves, triggered activity and torsade de pointes. J Am Coll Cardiol. 1994;23:259–277[Abstract]
  27. Derakhchan K, Cardinal R, Brunet S. Polymorphic ventricular tachycardias induced by d-sotalol and phenylephrine in canine preparations of atrioventricular block: initiation in the conduction system followed by spatially unstable re-entry. Cardiovasc Res. 1998;38:617–630[Abstract/Free Full Text]
  28. Shimizu W, Ohe T, Kurita T. Early afterdepolarizations induced by isoproterenol in patients with congenital long QT syndrome. Circulation. 1991;84:1915–1923[Abstract/Free Full Text]
  29. Shimizu W, Ohe T, Kurita T. Effects of verapamil and propranolol on early afterdepolarizations and ventricular arrhythmias induced by epinephrine in congenital long QT syndrome. J Am Coll Cardiol. 1995;26:1299–1309[Abstract]
  30. El-Sherif N, Caref EB, Yin H. The electrophysiological mechanism of ventricular arrhythmias in the long QT syndrome: Tridimensional mapping of activation and recovery patterns. Circ Res. 1996;79:474–492[Abstract/Free Full Text]
  31. El-Sherif N, Chinushi M, Caref EB. Electrophysiological mechanism of the characteristic electrocardiographic morphology of Torsade de Pointes tachyarrhythmias in the long-QT syndrome. Detailed analysis of ventricular tridimensional activation patterns. Circulation. 1997;96:4392–4399[Abstract/Free Full Text]
  32. Shimizu W, Antzelevitch C. Cellular basis for the electrocardiographic features of the LQT1 form of the long QT syndrome: Effects of b-adrenergic agonists, antagonists and sodium channel blockers on transmural dispersion of repolarization and Torsade de Pointes. Circulation. 1998;98:2314–2322[Abstract/Free Full Text]
  33. Shimizu W, Antzelevitch C. Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing Torsade de Pointes in LQT2 and LQT3 models of the long-QT syndrome. Circulation. 1997;96:2038–2047[Abstract/Free Full Text]
  34. Antzelevitch C, Sun ZQ, Zhang ZQ. Cellular and ionic mechanisms underlying erythromycin-induced long QT and torsade de pointes. J Am Coll Cardiol. 1996;28:1836–1848[Abstract]
  35. Yan GX, Antzelevitch C. Cellular basis for the normal T wave and the electrocardiographic manifestations of the long QT syndrome. Circulation. 1998;98:1928–1936[Abstract/Free Full Text]
  36. Weissenburger J, Nesterenko VV, Antzelevitch C. Transmural heterogeneity of ventricular repolarization under baseline and long QT conditions in the canine heart in vivo. Torsades de Pointes develops with halothane but not pentobarbital anesthesia. J Cardiovasc Electrophysiol. 2000;11:290–304[ISI][Medline]
  37. Asano Y, Davidenko JM, Baxter WT. Optical mapping of drug-induced polymorphic arrhythmias and torsade de pointes in the isolated rabbit heart. J Am Coll Cardiol. 1997;29:831–842[Abstract]
  38. Abildskov JA, Lux RL. The mechanism of simulated torsades de pointes in computer model of propagated excitation. J Cardiovasc Electrophysiol. 1991;2:224–237[CrossRef]
  39. Pertsov AM, Davidenko JM, Salomonsz R. Spiral waves of excitation underlie reentrant activity in isolated cardiac muscle. Circ Res. 1993;72:631–650[Abstract/Free Full Text]
  40. Fontaine G. A new look at torsades de pointes. Hashiba K, Moss AJ, Schwartz PJ. QT Prolongation and Ventricular Arrhythmias. New York: New York Academy of Science; 1992. p. 157–177
  41. Surawicz B. Electrophysiologic substrate of torsade de pointes: Dispersion of repolarization or early afterdepolarizations? J Am Coll Cardiol. 1989;14:172–184[Abstract]
  42. Antzelevitch C, Sicouri S, Litovsky SH. Heterogeneity within the ventricular wall: Electrophysiology and pharmacology of epicardial, endocardial and M cells. Circ Res. 1991;69:1427–1449[Free Full Text]
  43. Shimizu W, Antzelevitch C. Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome. J Am Coll Cardiol. 2000;35:778–786[Abstract/Free Full Text]
  44. van Opstal JM, Schoenmakers M, Verduyn SC. Chronic Amiodarone evokes no Torsade de Pointes arrhythmias despite QT lengthening in an animal model of acquired Long-QT Syndrome. Circulation. 2001;104:2722–2727[Abstract/Free Full Text]
  45. Antzelevitch C, Dumaine R. Electrical heterogeneity in the heart: Physiological, pharmacological and clinical implications. Page E, Fozzard HA, Solaro RJ. Handbook of Physiology. The Heart. New York: Oxford University Press; 2002. p. 654–692
  46. Gbadebo TD, Trimble RW, Khoo MS. Calmodulin inhibitor W-7 unmasks a novel electrocardiographic parameter that predicts initiation of torsade de pointes. Circulation. 2002;105:770–774[Abstract/Free Full Text]
  47. Li GR, Feng J, Yue L. Transmural heterogeneity of action potentials and Ito1 in myocytes isolated from the human right ventricle. Am J Physiol. 1998;275:H369–377
  48. Yan GX, Shimizu W, Antzelevitch C. Characteristics and distribution of M cells in arterially-perfused canine left ventricular wedge preparations. Circulation. 1998;98:1921–1927[Abstract/Free Full Text]
  49. Moss AJ, Zareba W, Benhorin J. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation. 1995;92:2929–2934[Abstract/Free Full Text]
  50. Zhang L, Timothy KW, Vincent GM. Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes. Circulation. 2000;102:2849–2855[Abstract/Free Full Text]
  51. Crampton RS. Preeminence of the left stellate ganglion in the long Q-T syndrome. Circulation. 1979;59:769–778[Abstract/Free Full Text]
  52. Schwartz PJ, Priori SG, Spazzolini C. Genotype–phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation. 2001;103:89–95
  53. Moss AJ, Zareba W, Hall WJ. Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation. 2000;101:616–623[Abstract/Free Full Text]
  54. Ali RH, Zareba W, Moss A. Clinical and genetic variables associated with acute arousal and nonarousal-related cardiac events among subjects with long QT syndrome. Am J Cardiol. 2000;85:457–461[CrossRef][ISI][Medline]
  55. Antzelevitch C. Transmural dispersion of repolarization and the T wave. Cardiovasc Res. 2001;50:426–431[Free Full Text]
  56. Tanabe Y, Inagaki M, Kurita T. Sympathetic stimulation produces a greater increase in both transmural and spatial dispersion of repolarization in LQT1 than LQT2 forms of congenital long QT syndrome. J Am Coll Cardiol. 2001;37:911–919[Abstract/Free Full Text]
  57. Dumaine R, Wang Q, Keating MT. Multiple mechanisms of Na+ channel-linked long-QT syndrome. Circ Res. 1996;78:916–924[Abstract/Free Full Text]
  58. Zygmunt AC, Eddlestone GT, Thomas GP. Larger late sodium conductance in M cells contributes to electrical heterogeneity in canine ventricle. Am J Physiol. 2001;281:H689–H697[ISI]
  59. Priori SG, Napolitano C, Cantu F. Differential response to Na+ channel blockade, b-adrenergic stimulation, and rapid pacing in a cellular model mimicking the SCN5A and HERG defects present in the long-QT syndrome. Circ Res. 1996;78:1009–1015[Abstract/Free Full Text]
  60. Noda T, Takaki H, Kurita T. Gene-specific response of dynamic ventricular repolarization to sympathetic stimulation in LQT1, LQT2 and LQT3 forms of congenital long QT syndrome. Eur Heart J. 2002;23:975–983[Abstract/Free Full Text]
  61. Shimizu W, Kamakura S, Ohe T. Diagnostic usefulness and response to epinephrine of body surface recovery time measured from 87-lead body surface potential mapping in congenital long QT syndrome. J Electrocardiol. 1995;28:86
  62. Ackerman MJ, Khositseth A, Tester DJ. Epinephrine-induced QT interval prolongation: a gene-specific paradoxical response in congenital long QT syndrome. Mayo Clin Proc. 2002;:
  63. Shimizu W, Noda T, Takaki H. Epinephrine unmasks latent gene carriers with LQT1 form of congenital long QT syndrome (Abstr). Circulation. 2001;104:I–192

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Therapeutic Advances in Respiratory DiseaseHome page
M. Cazzola and M. G. Matera
Review: Safety of long-acting {beta}2 -agonists in the treatment of asthma
Therapeutic Advances in Respiratory Disease, October 1, 2007; 1(1): 35 - 46.
[Abstract] [PDF]

Home page
 ChestHome page
C. Williams, H. S. Nelson, and P. M. Dorinsky
Cause of Death in the SMART Trial.
Chest, September 1, 2006; 130(3): 929 - 930.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
P. Ballo, D. Bernabo, and S. A. Faraguti
Abnormal QT responses to adenosine in subjects with long-QT syndrome
Eur. Heart J., July 2, 2006; 27(14): 1759 - 1760.
[Full Text] [PDF]

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Antzelevitch, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Antzelevitch, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?